Author FC was employed by Henan ANIMIC Biotechnology Co., Ltd., China
Avoid injecting cold medication
To finish up the side effects, the discontinuation rate excluding the weight loss stoppages appears at least a bit more reasonable as in most obesity trials the stop rate is usually 5-8% which only leaves the 12mg as an outlier still, but like I said earlier, we need side effects over time and just more data in general to see whats going on with that dose
That trial supports a 2024 FDA label expansion making semaglutide indicated for cardiovascular risk reduction in adults with overweight or obesity and prior CV disease
Federal health officials say some medications being sold may not contain the same active ingredient as FDA-approved semaglutide products
Sabatine MS, Giugliano RP, Keech AC, et al